| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology |
1 Microbiology and Tumor Biology Center and 2 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 3 Department of Biochemistry, National Cheng Kung University Medical College, Taiwan, Republic of China; and 4 Department of Pathology and Duke University School of Nursing, Duke University Medical Center, Durham, North Carolina
We have recently reported the identification of kringle 1-5 (K1-5) of plasminogen as a potent and specific inhibitor of angiogenesis and tumor growth. Here, we show that K1-5 bound to endothelial cell surface ATP synthase and triggered caspase-mediated endothelial cell apoptosis. Induction of endothelial apoptosis involved sequential activation of caspases-8, -9, and -3. Administration of neutralizing antibodies directed against the
- and ß-subunits of ATP synthase to endothelial cells attenuated activation of these caspases. Furthermore, inhibitors of caspases-3, -8, and -9 also remarkably blocked K1-5-induced endothelial cell apoptosis and antiangiogenic responses. In a mouse tumor model, we show that caspase-3 inhibitors abolished the antitumor activity of K1-5 by protecting the tumor vasculature undergoing apoptosis. These results suggest that the specificity of the antiendothelial effect of K1-5 is attributable, at least in part, to its interaction with the endothelial cell surface ATP synthase and that the caspase-mediated endothelial apoptosis is essential for the angiostatic activity of K1-5. Thus, our findings provide a mechanistic insight with respect to the angiostatic action and signaling pathway of K1-5 and angiostatin.
This article has been cited by other articles:
![]() |
H. Nakagawa, S. Yasuda, E. Matsuura, K. Kobayashi, M. Ieko, H. Kataoka, T. Horita, T. Atsumi, and T. Koike Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property Blood, September 17, 2009; 114(12): 2553 - 2559. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mu, D. A. Long, X. Ouyang, A. Agarwal, P. E. Cruz, C. A. Roncal, T. Nakagawa, X. Yu, W. W. Hauswirth, and R. J. Johnson Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism Am J Physiol Renal Physiol, January 1, 2009; 296(1): F145 - F152. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Shen, Z. F. Yang, Y. Gao, J. C. Li, H. X. Chen, C. C. Liu, R. T.P. Poon, S. T. Fan, J. M. Luk, K. H. Sze, et al. The Kringle 1 Domain of Hepatocyte Growth Factor Has Antiangiogenic and Antitumor Cell Effects on Hepatocellular Carcinoma Cancer Res., January 15, 2008; 68(2): 404 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. B. Nguyen, I. V. Subramanian, A. Kelekar, and S. Ramakrishnan Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells Blood, June 1, 2007; 109(11): 4793 - 4802. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schmitz, E. Raskopf, M. A. Gonzalez-Carmona, A. Vogt, C. Rabe, L. Leifeld, M. Kornek, T. Sauerbruch, and W. H Caselmann Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model Gut, February 1, 2007; 56(2): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, R. Guo, W. Li, J. Shao, S. Li, K. Zhao, X. Chen, N. Xu, S. Liu, and Y. Lu A proteomic investigation into a human gastric cancer cell line BGC823 treated with diallyl trisulfide Carcinogenesis, June 1, 2006; 27(6): 1222 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, Y.-J. Chuang, T. Jin, R. Swanson, Y. Xiong, L. Leung, and S. T. Olson Antiangiogenic antithrombin induces global changes in the gene expression profile of endothelial cells. Cancer Res., May 15, 2006; 66(10): 5047 - 5055. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Gunawardana, R. E. Martinez, W. Xiao, and D. M. Templeton Cadmium inhibits both intrinsic and extrinsic apoptotic pathways in renal mesangial cells Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1074 - F1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Carroll, L. L. Nikitenko, R. Bicknell, and A. L. Harris Antiangiogenic Activity of a Domain Deletion Mutant of Tissue Plasminogen Activator Containing Kringle 2 Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |